Ensysce Biosciences, Inc. (ENSC)
0.4767
0.00 (0.00%)
USD |
NASDAQ |
Sep 09, 12:39
Ensysce Biosciences Market Cap : 7.736M for Sept. 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 08, 2026 | 7.676M |
| September 04, 2026 | 7.395M |
| September 03, 2026 | 7.140M |
| September 02, 2026 | 7.186M |
| September 01, 2026 | 6.298M |
| August 31, 2026 | 6.372M |
| August 28, 2026 | 6.489M |
| August 27, 2026 | 6.475M |
| August 26, 2026 | 6.686M |
| August 25, 2026 | 6.540M |
| August 24, 2026 | 5.858M |
| August 21, 2026 | 6.058M |
| August 20, 2026 | 6.131M |
| August 19, 2026 | 6.296M |
| August 18, 2026 | 6.248M |
| August 17, 2026 | 6.111M |
| August 14, 2026 | 6.489M |
| August 13, 2026 | 5.655M |
| August 12, 2026 | 6.470M |
| August 11, 2026 | 6.824M |
| August 10, 2026 | 3.994M |
| August 07, 2026 | 4.826M |
| August 06, 2026 | 4.864M |
| August 05, 2026 | 3.359M |
| August 04, 2026 | 3.564M |
| Date | Value |
|---|---|
| August 03, 2026 | 2.599M |
| July 31, 2026 | 2.347M |
| July 30, 2026 | 2.384M |
| July 29, 2026 | 2.345M |
| July 28, 2026 | 2.329M |
| July 27, 2026 | 2.427M |
| July 24, 2026 | 2.425M |
| July 23, 2026 | 2.529M |
| July 22, 2026 | 2.630M |
| July 21, 2026 | 2.656M |
| July 20, 2026 | 2.502M |
| July 17, 2026 | 2.624M |
| July 16, 2026 | 2.574M |
| July 15, 2026 | 2.704M |
| July 14, 2026 | 2.714M |
| July 13, 2026 | 2.556M |
| July 10, 2026 | 2.504M |
| July 09, 2026 | 2.57M |
| July 08, 2026 | 2.551M |
| July 07, 2026 | 2.561M |
| July 06, 2026 | 2.735M |
| July 02, 2026 | 2.635M |
| July 01, 2026 | 2.799M |
| June 30, 2026 | 2.691M |
| June 29, 2026 | 2.753M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 11.91B |
| Oncolytics Biotech, Inc. | 100.76M |
| Sangamo Therapeutics, Inc. | 66.66M |
| Sarepta Therapeutics, Inc. | 2.345B |
| Anixa Biosciences, Inc. | 95.66M |
Market Cap Related Metrics
| PS Ratio | 0.7004 |
| Price | 0.4767 |
| Earnings Yield | -578.8% |